Total Payments
$9,523
2024 Payments
$1,325
Companies
59
Transactions
451
Medicare Patients
8,712
Medicare Billing
$618,483
Payment Breakdown by Category
Food & Beverage$8,575 (90.0%)
Education$948.61 (10.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,575 | 432 | 90.0% |
| Education | $948.61 | 19 | 10.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,621 | 83 | $0 (2024) |
| Janssen Biotech, Inc. | $1,318 | 59 | $0 (2024) |
| PFIZER INC. | $1,109 | 77 | $0 (2022) |
| C. R. Bard, Inc. & Subsidiaries | $494.33 | 13 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $490.31 | 22 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $345.48 | 19 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $257.34 | 12 | $0 (2024) |
| Boston Scientific Corporation | $241.21 | 6 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $237.78 | 12 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $228.34 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,325 | 50 | C. R. Bard, Inc. & Subsidiaries ($291.14) |
| 2023 | $1,446 | 53 | Telix Pharmaceuticals ($171.74) |
| 2022 | $1,304 | 49 | Astellas Pharma US Inc ($302.25) |
| 2021 | $1,063 | 49 | Astellas Pharma US Inc ($319.61) |
| 2020 | $811.33 | 44 | Astellas Pharma US Inc ($221.59) |
| 2019 | $1,721 | 91 | Astellas Pharma US Inc ($383.23) |
| 2018 | $944.79 | 65 | PFIZER INC. ($254.27) |
| 2017 | $908.27 | 50 | PFIZER INC. ($177.21) |
All Payment Transactions
451 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $23.17 | General |
| 12/18/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $37.71 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/18/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: UROLOGY | ||||||
| 11/22/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $67.91 | General |
| Category: Urology | ||||||
| 10/09/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Urology | ||||||
| 10/08/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: Urology | ||||||
| 10/08/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $3.12 | General |
| Category: Urology | ||||||
| 10/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: UROLOGY | ||||||
| 09/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $23.38 | General |
| 09/05/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/04/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: UROLOGY | ||||||
| 07/31/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 07/31/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA, AKEEGA | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Oncology | ||||||
| 07/06/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $26.47 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,248 | 2,830 | $464,180 | $153,938 |
| 2022 | 21 | 2,283 | 2,804 | $474,802 | $153,815 |
| 2021 | 23 | 2,254 | 2,824 | $487,797 | $168,956 |
| 2020 | 27 | 1,927 | 3,367 | $423,154 | $141,773 |
Total Patients
8,712
Total Services
11,825
Medicare Billing
$618,483
Procedure Codes
92
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 383 | 491 | $128,678 | $43,456 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 473 | 533 | $98,304 | $31,212 | 31.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 101 | 119 | $59,746 | $21,111 | 35.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 22 | 98 | $40,931 | $12,656 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $21,504 | $6,819 | 31.7% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 14 | 17 | $14,039 | $5,177 | 36.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 43 | 49 | $12,884 | $4,868 | 37.8% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 20 | 46 | $14,266 | $4,840 | 33.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 43 | 51 | $9,425 | $3,480 | 36.9% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 35 | 74 | $9,420 | $3,187 | 33.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 44 | $6,992 | $2,659 | 38.0% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 16 | 39 | $7,036 | $2,592 | 36.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 339 | 370 | $8,252 | $2,557 | 31.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 41 | 57 | $5,751 | $2,160 | 37.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 13 | 15 | $12,625 | $1,522 | 12.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 504 | 605 | $1,960 | $1,323 | 67.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 14 | 14 | $3,318 | $1,227 | 37.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,644 | $1,168 | 32.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 43 | 56 | $2,692 | $992.75 | 36.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 59 | $1,747 | $613.20 | 35.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 14 | $966.00 | $317.28 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 432 | 534 | $144,714 | $46,961 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 420 | 470 | $89,770 | $29,450 | 32.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 103 | 128 | $66,188 | $23,023 | 34.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 12 | 75 | $31,148 | $9,734 | 31.3% |
About Dr. John Heffernan, M.D
Dr. John Heffernan, M.D is a Urology healthcare provider based in Newport, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649243643.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Heffernan, M.D has received a total of $9,523 in payments from pharmaceutical and medical device companies, with $1,325 received in 2024. These payments were reported across 451 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($8,575).
As a Medicare-enrolled provider, Heffernan has provided services to 8,712 Medicare beneficiaries, totaling 11,825 services with total Medicare billing of $618,483. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Newport, RI
- Active Since 02/09/2006
- Last Updated 01/25/2010
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649243643
Products in Payments
- XTANDI (Drug) $1,473
- ERLEADA (Drug) $643.67
- Nubeqa (Drug) $470.75
- Erleada (Drug) $460.41
- Bard Urinary Drainage Bag (Device) $409.95
- XIAFLEX (Biological) $347.75
- GEMTESA (Drug) $341.63
- ZYTIGA (Drug) $263.03
- TOVIAZ (Drug) $260.64
- Xtandi (Drug) $219.74
- PROLARIS (Device) $191.72
- ILLUCCIX (Drug) $191.02
- FIRMAGON (Drug) $171.74
- Myrbetriq (Drug) $164.66
- MYRBETRIQ (Drug) $157.60
- PYLARIFY (Drug) $138.35
- XYOSTED (Drug) $133.98
- KEYTRUDA (Biological) $131.82
- ELIGARD (Drug) $118.25
- AQUABEAM ROBOTIC SYSTEM (Device) $112.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Newport
Dr. Noah Allen, M.d, M.D
Urology — Payments: $9,900
Urology $9,900
Samuel Eaton, M.d, M.D
Urology — Payments: $8,880
Urology $8,880
Dr. Joseph Heineman, M.d, M.D
Urology — Payments: $6,799
Urology $6,799
Javier Felipe-Morales, Md, MD
Urology — Payments: $5,294
Urology $5,294
Dr. Arnold Sarazen, M.d, M.D
Urology — Payments: $4,103
Urology $4,103
Dr. Laura Bertrand, M.d, M.D
Urology — Payments: $3,554
Urology $3,554